advertisement
Funke S 23
Showing records 1 to 23 | Display all abstracts from Funke S73546 Decelerated neurodegeneration after intravitreal injection of α-synuclein antibodies in a glaucoma animal model
Teister J
Scientific reports 2017; 7: 6260
72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Anders F
PLoS ONE 2017; 12: e0175451
72603 The potential impact of recent insights into proteomic changes associated with glaucoma
Funke S
Expert review of proteomics 2017; 14: 311-334
73128 Proteomic profiling reveals crucial retinal protein alterations in the early phase of an experimental glaucoma model
Anders F
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 1395-1407
72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Teister J
PLoS ONE 2017; 12: e0175451
73128 Proteomic profiling reveals crucial retinal protein alterations in the early phase of an experimental glaucoma model
Teister J
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 1395-1407
73546 Decelerated neurodegeneration after intravitreal injection of α-synuclein antibodies in a glaucoma animal model
Anders F
Scientific reports 2017; 7: 6260
72603 The potential impact of recent insights into proteomic changes associated with glaucoma
Perumal N; Bell K
Expert review of proteomics 2017; 14: 311-334
72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Liu A
PLoS ONE 2017; 12: e0175451
73128 Proteomic profiling reveals crucial retinal protein alterations in the early phase of an experimental glaucoma model
Funke S
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 1395-1407
73546 Decelerated neurodegeneration after intravitreal injection of α-synuclein antibodies in a glaucoma animal model
Beck S; Funke S
Scientific reports 2017; 7: 6260
72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Funke S
PLoS ONE 2017; 12: e0175451
73128 Proteomic profiling reveals crucial retinal protein alterations in the early phase of an experimental glaucoma model
Pfeiffer N
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 1395-1407
72603 The potential impact of recent insights into proteomic changes associated with glaucoma
Pfeiffer N; Grus FH
Expert review of proteomics 2017; 14: 311-334
73546 Decelerated neurodegeneration after intravitreal injection of α-synuclein antibodies in a glaucoma animal model
von Pein H
Scientific reports 2017; 7: 6260
73128 Proteomic profiling reveals crucial retinal protein alterations in the early phase of an experimental glaucoma model
Grus F
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 1395-1407
72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Grus FH
PLoS ONE 2017; 12: e0175451
73546 Decelerated neurodegeneration after intravitreal injection of α-synuclein antibodies in a glaucoma animal model
Prokosch V
Scientific reports 2017; 7: 6260
73128 Proteomic profiling reveals crucial retinal protein alterations in the early phase of an experimental glaucoma model
Solon T
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 1395-1407
72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Thanos S; von Pein HD
PLoS ONE 2017; 12: e0175451
73128 Proteomic profiling reveals crucial retinal protein alterations in the early phase of an experimental glaucoma model
Prokosch V
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 1395-1407
73546 Decelerated neurodegeneration after intravitreal injection of α-synuclein antibodies in a glaucoma animal model
Pfeiffer N; Grus F
Scientific reports 2017; 7: 6260
72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Pfeiffer N; Prokosch V
PLoS ONE 2017; 12: e0175451
